chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://79bcf7a1-8b8e-483b-b7cf-f5c5192a6d63.usrfiles.com/ugd/79bcf7_c5813c517d9f4ca5aacbeb719508827a.pdf In other words, Blarcamesine restored dysregulated genes associated with Alzheimer's and Parkinson's. If so, was that restoration evident in all patients treated with Blarcamesine versus no restoration in the placebo patients? More importantly, did all treated patients show some degree of improvement or decline in the progression of the diseases? Or was it that the restoration occurred only in those patients treated with the Blarcamesine high dose?
News 
Market Data 
Discover 
